| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |